Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Low-to-intermediate-risk Prostate Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 0 results

Not applicableEnded earlyNCT05826470
What this trial is testing

Investigator Initiated Trial to Further Evaluate the Safety and Efficacy of Trans-perineal Focal Laser Ablation of Localized Prostate Cancer Using High Frequency Micro-ultrasound Imaging

Who this might be right for
Prostate CancerLow-risk or Favorable Intermediate Risk Prostate Cancer Who Are on an Active Surveillance Regimen
Genesis Research LLC 4
Not applicableStudy completedNCT01780701
What this trial is testing

Magnetic Resonance Spectroscopic Imaging Study of Prostatic Fats to Distinguish the Difference Between High and Low Risk Prostate Cancer

Who this might be right for
Prostate Cancer
OHSU Knight Cancer Institute 66
Testing effectiveness (Phase 2)Looking for participantsNCT06347705
What this trial is testing

2141-V11 in Combination With Standard Treatments in People With Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 57
Not applicableNot Yet RecruitingNCT07210502
What this trial is testing

Side Effects of Low Dose Rate Brachytherapy and Ultra-hypofractionated Radiotherapy in Low to Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Adenocarcinoma
Royal Surrey County Hospital NHS Foundation Trust 220
Not applicableLooking for participantsNCT05722392
What this trial is testing

Safety and Efficacy of Two-step Radical Prostatectomy

Who this might be right for
Prostate Cancer
Sun Yat-sen University 30
Not applicableStudy completedNCT02104362
What this trial is testing

Single Fraction Early Prostate Irradiation (SiFEPI)

Who this might be right for
Prostate Cancer
Centre Antoine Lacassagne 35
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07152067
What this trial is testing

Stereotactic Focal Radiotherapy as an Alternative Treatment to Active Surveillance for Low and Intermediate Risk Prostate Cancer

Who this might be right for
Macroscopic Tumor Visualized at MRITumor Size Allowing Partial Prostate Treatment VolumeCAPRA SCORE ≤5
Centre Hospitalier Universitaire de Liege 146
Large-scale testing (Phase 3)Active Not RecruitingNCT02692105
What this trial is testing

Comparison of HDR vs. LDR Brachytherapy as Monotherapy for Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
British Columbia Cancer Agency 60
Not applicableEnded earlyNCT02454517
What this trial is testing

Diet and Exercise Program to Promote Weight Loss and Improve Health in Men With Low- or Low-Intermediate-Risk Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage I Prostate Cancer AJCC V7Stage IIA Prostate Cancer AJCC v7
Fred Hutchinson Cancer Center 117
Testing effectiveness (Phase 2)Study completedNCT02499848
What this trial is testing

Evaluate, Safety and Tolerability of Intraprostatic PRX302 Administration, Low to Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Sophiris Bio Corp 18
Not applicableStudy completedNCT02361515
What this trial is testing

Hypofractionated Radiotherapy Versus Stereotactic Irradiation With Hyaluronic Acid

Who this might be right for
Prostatic Adenocarcinoma
Hospices Civils de Lyon 96